{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:01:47Z","timestamp":1740124907404,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41443-019-0126-y","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T15:07:54Z","timestamp":1549984074000},"page":"439-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Variation in collagenase Clostridium histolyticum practice patterns: a Survey of ISSM Members"],"prefix":"10.1038","volume":"31","author":[{"given":"T. A.","family":"Masterson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Galante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4760-4026","authenticated-orcid":false,"given":"M.","family":"Butaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pastuszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Sadeghi-Nejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"key":"126_CR1","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","volume":"7","author":"D Ralph","year":"2010","unstructured":"Ralph D, Gonzalez-Cadavid N, Milrone V, Perovic S, Sohn M, Usta M, et al. The management of Peyronie\u2019s disease: evidence-based 2010 guidelines. J Sex Med. 2010;7:2359\u201374.","journal-title":"J Sex Med"},{"key":"126_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","volume":"194","author":"A Nehra","year":"2015","unstructured":"Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, et al. Peyronie\u2019s disease: AUA guideline. J Urol. 2015;194:745\u201353.","journal-title":"J Urol"},{"key":"126_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199\u2013207.","journal-title":"J Urol"},{"key":"126_CR4","unstructured":"Highlights of Prescribing Information [Internet]. Endo Pharmaceuticals, Inc.; 2018. \nhttp:\/\/www.endo.com\/File.Library\/Products\/Prescribing.Information\/Xiaflex_prescribing_information.html\n\n. Accessed 13 Dec 2018."},{"key":"126_CR5","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.jsxm.2017.08.008","volume":"14","author":"HMT Nguyen","year":"2017","unstructured":"Nguyen HMT, Anaissie J, DeLay KJ, Yafi FA, Sikka SC, Hellstrom WJG. Safety and efficacy of collagenase Clostridium histolyticum in the treatment of acute-phase Peyronie\u2019s disease. J Sex Med. 2017;14:1220\u20135.","journal-title":"J Sex Med"},{"key":"126_CR6","doi-asserted-by":"publisher","first-page":"237 e9","DOI":"10.1016\/j.urology.2017.05.004","volume":"106","author":"WJG Hellstrom","year":"2017","unstructured":"Hellstrom WJG, Tan RBW, Liu G. Safety profile of collagenase Clostridium histolyticum stratified by degree of penile curvature in patients with Peyronie disease. Urology. 2017;106:237 e9\u2013237 e14.","journal-title":"Urology"},{"key":"126_CR7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jsxm.2018.03.084","volume":"15","author":"A Cocci","year":"2018","unstructured":"Cocci A, Russo GI, Salonia A, Cito G, Regis F, Polloni G, et al. Predictive factors of patients\u2019 and their partners\u2019 sexual function improvement after collagenase Clostridium histolyticum injection for Peyronie\u2019s disease: results from a Multi-Center Single-Arm Study. J Sex Med. 2018;15:716\u201321.","journal-title":"J Sex Med"},{"key":"126_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/bju.13932","volume":"120","author":"A Abdel Raheem","year":"2017","unstructured":"Abdel Raheem A, Capece M, Kalejaiye O, Abdel-Raheem T, Falcone M, Johnson M, et al. Safety and effectiveness of collagenase Clostridium histolyticum in the treatment of Peyronie\u2019s disease using a new modified shortened protocol. BJU Int. 2017;120:717\u201323.","journal-title":"BJU Int"},{"key":"126_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.21037\/tau.2016.03.15","volume":"5","author":"W Chong","year":"2016","unstructured":"Chong W, Tan RB. Injectable therapy for Peyronie\u2019s disease. Transl Androl Urol. 2016;5:310\u20137.","journal-title":"Transl Androl Urol"},{"key":"126_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.sxmr.2017.03.005","volume":"6","author":"AT Gabrielson","year":"2018","unstructured":"Gabrielson AT, Spitz JT, Hellstrom WJG. Collagenase lostridium histolyticum in the treatment of urologic disease: current and future impact. Sex Med Rev. 2018;6:143\u201356.","journal-title":"Sex Med Rev"},{"key":"126_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.urology.2018.06.003","volume":"119","author":"K Wymer","year":"2018","unstructured":"Wymer K, Zielgelmann M, Savage J, Kohler T, Trost L. Plaque calcification: an important predictor of collagenase lostridium histolyticum treatment outcomes for men with Peyronie\u2019s disease. Urology. 2018;119:109\u201314.","journal-title":"Urology"},{"key":"126_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jsxm.2016.02.105","volume":"13","author":"FA Yafi","year":"2016","unstructured":"Yafi FA, Anaissie J, Zurawin J, Sikka S, Hellstrom WJG. Results of SMSNA Survey regarding complications following intralesional injection thearpy with collagenase Clostridium histolyticum for Peyronie\u2019s disease. J Sex Med. 2016;13:684\u20139.","journal-title":"J Sex Med"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41443-019-0126-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-019-0126-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-019-0126-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:29:06Z","timestamp":1684618146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-019-0126-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,12]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1038\/s41443-019-0126-y","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"type":"print","value":"0955-9930"},{"type":"electronic","value":"1476-5489"}],"subject":[],"published":{"date-parts":[[2019,2,12]]},"assertion":[{"value":"6 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Ramasamy has previously received a research grant from Endo Pharmaceuticals which was unrelated to this study. Dr. Pastuszak is a consultant\/speaker for Endo Pharmaceuticals. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}